Sangamo BioSciences | SGMO - EPS Earnings Per Share


Sangamo BioSciences reported $-0.18 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cipla INR 9.76 2.9 Jun/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Grifols EUR 0.16 0.02 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.75 0.09 Mar/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026